APA (7th ed.) Citation

Worst, T. S., Weis, C., Stöhr, R., Bertz, S., Eckstein, M., Otto, W., . . . Erben, P. (2018). CDKN2A as transcriptomic marker for muscle-invasive bladder cancer risk stratification and therapy decision-making. Scientific Reports, 8(1), 1. https://doi.org/10.1038/s41598-018-32569-x

Chicago Style (17th ed.) Citation

Worst, Thomas S., et al. "CDKN2A as Transcriptomic Marker for Muscle-invasive Bladder Cancer Risk Stratification and Therapy Decision-making." Scientific Reports 8, no. 1 (2018): 1. https://doi.org/10.1038/s41598-018-32569-x.

MLA (9th ed.) Citation

Worst, Thomas S., et al. "CDKN2A as Transcriptomic Marker for Muscle-invasive Bladder Cancer Risk Stratification and Therapy Decision-making." Scientific Reports, vol. 8, no. 1, 2018, p. 1, https://doi.org/10.1038/s41598-018-32569-x.